These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32575676)

  • 1. Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing.
    Noguera-Julian M; Lee ER; Shafer RW; Kantor R; Ji H
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32575676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations.
    Ji H; Parkin N; Gao F; Denny T; Jennings C; Sandstrom P; Kantor R
    Viruses; 2020 May; 12(5):. PubMed ID: 32443529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges.
    Lee ER; Gao F; Sandstrom P; Ji H
    Viruses; 2020 May; 12(5):. PubMed ID: 32429382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg Consensus.
    Ji H; Enns E; Brumme CJ; Parkin N; Howison M; Lee ER; Capina R; Marinier E; Avila-Rios S; Sandstrom P; Van Domselaar G; Harrigan R; Paredes R; Kantor R; Noguera-Julian M
    J Int AIDS Soc; 2018 Oct; 21(10):e25193. PubMed ID: 30350345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations.
    Ávila-Ríos S; Parkin N; Swanstrom R; Paredes R; Shafer R; Ji H; Kantor R
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32516949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing.
    Jennings C; Parkin NT; Zaccaro DJ; Capina R; Sandstrom P; Ji H; Brambilla DJ; Bremer JW
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33348705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing.
    Lee ER; Parkin N; Jennings C; Brumme CJ; Enns E; Casadellà M; Howison M; Coetzer M; Avila-Rios S; Capina R; Marinier E; Van Domselaar G; Noguera-Julian M; Kirkby D; Knaggs J; Harrigan R; Quiñones-Mateu M; Paredes R; Kantor R; Sandstrom P; Ji H
    Sci Rep; 2020 Jan; 10(1):1634. PubMed ID: 32005884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are We Ready for NGS HIV Drug Resistance Testing? The Second "Winnipeg Consensus" Symposium.
    Ji H; Sandstrom P; Paredes R; Harrigan PR; Brumme CJ; Avila Rios S; Noguera-Julian M; Parkin N; Kantor R
    Viruses; 2020 May; 12(6):. PubMed ID: 32471096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Application of Performance Assessment Criteria for Next-Generation Sequencing-Based HIV Drug Resistance Assays.
    Becker MG; Liang D; Cooper B; Le Y; Taylor T; Lee ER; Wu S; Sandstrom P; Ji H
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32532083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Automatic Analysis of Ultradeep Pyrosequencing Raw Data to Determine Percentages of HIV Resistance Mutations in Patients Followed-Up in Hospital.
    Bellecave P; Recordon-Pinson P; Fleury H
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):85-92. PubMed ID: 26529549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.
    Alidjinou EK; Deldalle J; Hallaert C; Robineau O; Ajana F; Choisy P; Hober D; Bocket L
    J Antimicrob Chemother; 2017 Oct; 72(10):2823-2830. PubMed ID: 29091197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next generation sequencing based in-house HIV genotyping method: validation report.
    Ayitewala A; Ssewanyana I; Kiyaga C
    AIDS Res Ther; 2021 Oct; 18(1):64. PubMed ID: 34600538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.
    Raymond S; Nicot F; Carcenac R; Lefebvre C; Jeanne N; Saune K; Delobel P; Izopet J
    J Antimicrob Chemother; 2018 May; 73(5):1152-1157. PubMed ID: 29444253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.
    Alidjinou EK; Coulon P; Hallaert C; Robineau O; Meybeck A; Huleux T; Ajana F; Hober D; Bocket L
    J Clin Virol; 2019 Dec; 121():104207. PubMed ID: 31707202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of an
    Tzou PL; Ariyaratne P; Varghese V; Lee C; Rakhmanaliev E; Villy C; Yee M; Tan K; Michel G; Pinsky BA; Shafer RW
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Drug Resistance Assay Using Ion Torrent Next Generation Sequencing and On-Instrument End-to-End Analysis Software.
    Pyne MT; Simmon KE; Mallory MA; Hymas WC; Stevenson J; Barker AP; Hillyard DR
    J Clin Microbiol; 2022 Jul; 60(7):e0025322. PubMed ID: 35699434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy.
    Armenia D; Carioti L; Micheli V; Bon I; Allice T; Bonura C; Bruzzone B; Bracchitta F; Cerutti F; Giammanco GM; Stefanelli F; Bonifacio MA; Bertoli A; Vatteroni M; Ibba G; Novazzi F; Lipsi MR; Cuomo N; Vicenti I; Ceccherini-Silberstein F; Rossetti B; Bezenchek A; Saladini F; Zazzi M; Santoro MM;
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.
    May S; Adamska E; Tang J
    J Clin Virol; 2020 Jun; 127():104376. PubMed ID: 32344322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework.
    Capina R; Li K; Kearney L; Vandamme AM; Harrigan PR; Van Laethem K
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32545906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.
    Nanfack AJ; Redd AD; Bimela JS; Ncham G; Achem E; Banin AN; Kirkpatrick AR; Porcella SF; Agyingi LA; Meli J; Colizzi V; Nádas A; Gorny MK; Nyambi PN; Quinn TC; Duerr R
    J Clin Microbiol; 2017 Sep; 55(9):2785-2800. PubMed ID: 28659324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.